Four-Factor Prognostic Model for the Prediction of Outcome in Patients With CLL Treated With Ibrutinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model
J. Clin. Oncol 2020 Oct 07;[EPub Ahead of Print], IE Ahn, X Tian, D Ipe, M Cheng, M Albitar, LC Tsao, L Zhang, W Ma, SEM Herman, EM Gaglione, S Soto, JP Dean, A WiestnerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.